TITLE:
Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224)

CONDITION:
Hypercholesterolemia

INTERVENTION:
MK0733, simvastatin

SUMMARY:

      The purpose of this study is to evaluate the safety and effectiveness of two approved drugs
      in lowering high cholesterol when taken together, compared to taking only one of the drugs.
    

DETAILED DESCRIPTION:

      The duration of treatment is 12 weeks.
    

ELIGIBILITY:
Gender: All
Age: 21 Years to 65 Years
Criteria:

        Inclusion Criteria:

          -  Elevated cholesterol level

        Exclusion Criteria:

          -  Liver disease

          -  Known allergies to study drugs
      
